Looks like you clickedhttps://investors.pfizer.com/investor-news/press-release-details/2018/Astellas-and-Pfizer-Announce-Positive-Top-Line-Results-from-Phase-3-ARCHES-Trial-of-XTANDI-enzalutamide-in-Men-with-Metastatic-Hormone-Sensitive-Prostate-Cancer/default.aspx
If you do not want to visit that page, you can close this browser tab.
